Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Droloxifene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 13/20 | 0.82 |
| ▸ | ESR2 known ✓ | Q92731 | 5/20 | 0.82 |
| ▸ | MAPT | P10636 | 3/20 | 0.82 |
| ▸ | MEN1 | O00255 | 3/20 | 0.82 |
| ▸ | TP53 | P04637 | 3/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.82 |
| ▸ | ESRRG | P62508 | 3/20 | 0.82 |
| ▸ | PGR | P06401 | 2/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.82 |
| ▸ | LMNA | P02545 | 2/20 | 0.82 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.82 |
| ▸ | ESRRB | O95718 | 2/20 | 0.82 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.82 |
| ▸ | PLD2 | O14939 | 1/20 | 0.82 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.82 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.81 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.81 |
| ▸ | NPC1 | O15118 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Droloxifene SCHEMBL5030004 | 1.00 | ESR1 (0.82) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL28151286 | 1.00 | ESR1 (0.82) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL30728607 | 1.00 | ESR1 (0.82) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL4842 | 1.00 | ESR1 (0.82) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL1151787 | 1.00 | ESR1 (0.82) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL4843 | 1.00 | ESR1 (0.82) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL9782633 | 0.99 | ESR1 (0.80) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL28095331 | 0.99 | ESR1 (0.80) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL750110 | 0.99 | ESR1 (0.80) | ESR1ESR2MAPTMEN1TP53 | |
| Droloxifene SCHEMBL28095329 | 0.99 | ESR1 (0.80) | ESR1ESR2MAPTMEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310385-A1 | TREATMENT OF ER-NEGATIVE BREAST CANCER WITH AN PDGF-CC INHIBITOR AND AN ANTI-ESTROGEN | PARACRINE THERAPEUTICS AB (SE) | 2023-10-05 | — | — | US | disclosed |
| CN-108348605-B | Treatment of ER-negative breast cancer with PDGF-CC inhibitors and antiestrogens | 帕拉卡林治疗公司 | 2023-06-09 | — | — | CN | disclosed |